About Geistlich

Geistlich Pharma specializes in the regeneration of bone, cartilage and tissue. Geistlich’s regenerative medical devices aim to improve patients’ quality of life.

More than 700 employees worldwide work for Geistlich in the area of regenerative medicine. With its twelve affiliates and 60 distribution partners, Geistlich’s medical devices and medicinal products reach around 90 markets worldwide. The twelve affiliates cover the UK, Germany, Italy, France, China, Brazil, South Korea, North America, Australia, New Zealand, India and Japan.

Read more about Geistlich HERE

•  Severe OCD of the medial femoral condyle of a 44 year old mountain farmer

Orthoss® Case Report KNEE

By: PROF. ROLAND JAKOB, FRIBOURG, SWITZERLAND read HERE

• Autologous Matrix-Induced Chondrogenesis (AMIC)and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study read HERE

About Tomasz Piontek

A graduate of the Poznan University of Medical Sciences. He had obtained his first degree of specialization in orthopedics and traumatology in 1999, four years later he passed the second degree of specialization, and in 2005 he defended his doctoral thesis. Tomasz Piontek is an international trainer of arthroscopic knee and hip surgical techniques.

Since 2006, Tomasz Piontek has been a doctor at Rehasport Clinic. Previously, he had worked, among others, in the Department of Paediatric Orthopaedics in Poznan, was the first football physician of Amica Wronki, and then served the same function in Lech Poznan. He had completed internships in Balgrist University Clinic in Zurich, Department of Orthopedics and Traumatology of Sports Medicine, Queens Medical Centre in the UK, and the University of Pittsburgh- Department of Orthopaedic Surgery, in the United States.

About PD Dr. Justus Gille

PD Dr. Justus Gille is a specialist in orthopaedics and accident surgery at the campus of Lübeck, UKSH, he received the Herbert Lauterbach Prize from the Association of Professional Cooperative Clinics for outstanding scientific achievements in the field of accident medicine. He was honoured for his research into the so-called autologous matrix-induced chondrogenesis (AMIC), an innovative method of cartilage replacement therapy.PD Dr. Gille is a senior physician in the Department of Trauma Surgery at the Clinic for Surgery of the Support and Movement Apparatus of the UKSH. The prize was awarded at the German Congress for Orthopaedics and Trauma Surgery in Berlin.”Both injuries from sports injuries and accidents at work can lead to direct damage to the articular cartilage,” explains Dr. Gille. “Because of the lack of sp such as the AMIC is particularly important in young people.”The work was published in two international journals in 2010 and has been approved by the Medical Faculty of the University of Lübeck as a habilitation thesis. ontaneous regeneration of articular cartilage after structural defects, a curative therapy